Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (151-160 of 333) with videos related to

Pageof 34
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1975
A rapid method for establishing short-term primary cultures of human tumor cells from fresh tumor biopsiesG M Mavligit, P B Barsales, J U Gutterman, et al.
Blood|July 1, 1970
Melphalan therapy of polycythemia veraG L Logue, J U Gutterman, T G McGinn, et al.
The New England Journal of Medicine|January 5, 1984
Alpha interferon for induction of remission in hairy-cell leukemiaJ R Quesada, J Reuben, J T Manning, et al.
International Journal of Cancer|September 15, 1974
Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancyU Ambus, G M Mavlight, J U Gutterman, et al.
Cancer Research|September 1, 1984
Pharmacokinetic study of partially pure gamma-interferon in cancer patientsJ U Gutterman, M G Rosenblum, A Rios, et al.
Biochemical Pharmacology|July 1, 1976
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatmentD Farquhar, T L Loo, J U Gutterman, et al.
International Journal of Cancer|May 1, 1973
Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsivenessJ U Gutterman, G Mavligit, K B McCredie, et al.
JAMA|September 13, 1985
Immune thrombocytopenia following alpha-interferon therapy in patients with cancerP McLaughlin, M Talpaz, J R Quesada, et al.
Cancer|May 1, 1977
Histiocytic lymphoma in the brain as the only manifestation of relapse following remission maintainance with BCG immunotherapyR D Snyder, G M Mavligit, M Valdivieso, et al.
Cancer|November 15, 1991
A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemiaM Talpaz, R Kurzrock, H Kantarjian, et al.
Pageof 34

Showing results (151-160 of 333) with videos related to

Sort By:
Pageof 34
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1975
A rapid method for establishing short-term primary cultures of human tumor cells from fresh tumor biopsiesG M Mavligit, P B Barsales, J U Gutterman, et al.
Blood|July 1, 1970
Melphalan therapy of polycythemia veraG L Logue, J U Gutterman, T G McGinn, et al.
The New England Journal of Medicine|January 5, 1984
Alpha interferon for induction of remission in hairy-cell leukemiaJ R Quesada, J Reuben, J T Manning, et al.
International Journal of Cancer|September 15, 1974
Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancyU Ambus, G M Mavlight, J U Gutterman, et al.
Cancer Research|September 1, 1984
Pharmacokinetic study of partially pure gamma-interferon in cancer patientsJ U Gutterman, M G Rosenblum, A Rios, et al.
Biochemical Pharmacology|July 1, 1976
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatmentD Farquhar, T L Loo, J U Gutterman, et al.
International Journal of Cancer|May 1, 1973
Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsivenessJ U Gutterman, G Mavligit, K B McCredie, et al.
JAMA|September 13, 1985
Immune thrombocytopenia following alpha-interferon therapy in patients with cancerP McLaughlin, M Talpaz, J R Quesada, et al.
Cancer|May 1, 1977
Histiocytic lymphoma in the brain as the only manifestation of relapse following remission maintainance with BCG immunotherapyR D Snyder, G M Mavligit, M Valdivieso, et al.
Cancer|November 15, 1991
A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemiaM Talpaz, R Kurzrock, H Kantarjian, et al.
Pageof 34